How many insider trades does FilingIQ track for AZN?

FilingIQ tracks 6 Form 4 insider transactions for AZN (ASTRAZENECA PLC), covering filings from Apr 7, 2026 onwards. 3 of those were filed in the last 90 days.

Are AZN insiders net buyers or net sellers?

Across the full Form 4 history for AZN, 0 transactions (0%) were open-market purchases and 1 (17%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does AZN insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is AZN in?

ASTRAZENECA PLC (AZN) is classified in the Healthcare sector, specifically Drug Manufacturers - General, with a current market capitalisation of $266.15B.

AZN insider trading

NYSE Healthcare

ASTRAZENECA PLC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

0% / 17%

Market cap

$266.15B

About ASTRAZENECA PLC

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Onglyza, Symlin, XIGDUO XR, Atacand, Atacand HCT, Atacand Plus, Farxiga/Forxiga, Plendil, Modip, Splendil, Munobal, Flodil, Tenormin, Tenormine, Prenormine, Atenol, Zestril, Brilinta/Brilique, Komboglyze, Qtern, Wainua, Byetta, Lokelma, Seloken ZOK, Toprol-XL, Betaloc ZOK, XIGDUO, Accolate, Accoleit, Vanticon, Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Pulmicort Turbuhaler, Symbicort Turbuhaler, Airsupra, Bricanyl Turbuhaler, Fasenra, Rhinocort, Tezspire, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Saphnelo, Breztri Aerosphere, Duaklir Genuair, Pulmicort Respules, and Symbicort pMDI. It also provides Beyfortus, Kavigale, Evusheld, Fluenz/FluMist, Synagis, Kanuma, Ultomiris, Koselugo, Voydeya, Soliris, Strensiq, Nexium, and other medicines. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, the Americas, rest of Europe, Asia, Africa, and Australasia. It has a strategic agreement with Tempus and Pathos to develop the largest multimodal foundation model in oncology; CSPC Pharmaceutical Group Limited to advance the discovery and development of novel oral candidates, with the potential to treat diseases across multiple indications; and Nucs AI Inc. to develop AI-driven Response Prediction for Therapeutic Radioconjugates. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Company website: www.astrazeneca.com

AZN insider activity at a glance

FilingIQ has scored 6 insider transactions for AZN since Apr 7, 2026. The most recent filing in our index is dated Aug 6, 2026.

Across the full history, 0 open-market purchases and 1 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on AZN insider trades is 64.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live AZN trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 983

UNITED THERAPEUTICS Corp

NUVL 195

Nuvalent, Inc.

KYMR 193

Kymera Therapeutics, Inc.

GH 192

Guardant Health, Inc.

Hims & Hers Health, Inc.

13F funds holding AZN

GQG Partners LLC

$486.09M · 2.1% of AUM

SCHARF INVESTMENTS, LLC

$63.02M · 1.9% of AUM

Hardman Johnston Global Advisors LLC

$61.81M · 1.7% of AUM

PFM Health Sciences, LP

$54.72M · 1.9% of AUM

CIDEL ASSET MANAGEMENT INC

$38.16M · 1.6% of AUM

Politicians who have traded AZN

Armstrong, Alan

U.S. Sen. · 703 trades

Frequently asked

How many insider trades does FilingIQ track for AZN?: FilingIQ tracks 6 Form 4 insider transactions for AZN (ASTRAZENECA PLC), covering filings from Apr 7, 2026 onwards. 3 of those were filed in the last 90 days.
Are AZN insiders net buyers or net sellers?: Across the full Form 4 history for AZN, 0 transactions (0%) were open-market purchases and 1 (17%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does AZN insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is AZN in?: ASTRAZENECA PLC (AZN) is classified in the Healthcare sector, specifically Drug Manufacturers - General, with a current market capitalisation of $266.15B.

Methodology & sources

Every AZN insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.